Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | TERT | O14746 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20771517 | 1.00 | EP300 (0.60) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL11439397 | 1.00 | EP300 (0.60) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL10788834 | 1.00 | EP300 (0.60) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL4914440 | 1.00 | EP300 (0.60) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL6067678 | 0.98 | EP300 (0.57) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL13269486 | 0.94 | EP300 (0.57) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL6067615 | 0.92 | NPSR1 (0.50) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL12693568 | 0.91 | GLO1 (0.56) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL11717792 | 0.91 | GLO1 (0.56) | EP300FAAHNPSR1GLO1ALDH1A1 | |
| SCHEMBL4926110 | 0.91 | GLO1 (0.56) | EP300FAAHNPSR1GLO1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | claimed |
| EP-1838278-A1 | 2-C-SUBSTITUTED PROPANE-1,3-DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | Givaudan SA (CH) | 2007-10-03 | — | — | EP | claimed |
| WO-2006076821-A1 | 2 -C-SUBSTITUTED PROPANE-1, 3 -DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | GIVAUDAN SA (CH) | 2006-07-27 | — | — | WO | claimed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| WO-2022167123-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
| US-9585362-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2017-03-07 | — | — | US | disclosed |
| US-9585362-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2017-03-07 | — | — | US | disclosed |
| US-20160286753-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2016-10-06 | — | — | US | disclosed |
| US-20160286753-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2016-10-06 | — | — | US | disclosed |
| EP-2032516-B1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2012-09-26 | — | — | EP | disclosed |
| US-20090202464-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2009-08-13 | — | — | US | disclosed |
| US-20090202464-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2009-08-13 | — | — | US | disclosed |
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | disclosed |
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | disclosed |
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | disclosed |
| WO-2007143873-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2007-12-21 | — | — | WO | disclosed |
| EP-1838278-A1 | 2-C-SUBSTITUTED PROPANE-1,3-DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | Givaudan SA (CH) | 2007-10-03 | — | — | EP | disclosed |
| WO-2006076821-A1 | 2 -C-SUBSTITUTED PROPANE-1, 3 -DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | GIVAUDAN SA (CH) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202464-A1 | Fragrance Compounds | OR10J3, OR51E2, TAS2R5 | EP300 929/4885FAAH 1234/4885NPSR1 69/4885 |
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | TYR, MAL2, ACMSD | EP300 2098/4885FAAH 1305/4885NPSR1 4097/4885 |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | EP300 2974/4885FAAH 961/4885NPSR1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.